Showing 76-80 of 90 predictive & prescriptive analytics:
OM1 Heart Failure Registry Reaches More Than 140,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, Jan. 28, 2021 /PRNewswire/ — OM1, a leading real-world data (RWD), outcomes and technology company with a focus on chronic diseases, today announced the launch of an expanded Heart Failure registry. Heart Failure (HF) is considered a growing healthcare epidemic and is associated with significant mortality, morbidity and resource utilization. In the United States, HF is estimated to[…]

OM1 Giant Cell Arteritis Registry Reaches More Than 5,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, Dec. 8, 2020 /PRNewswire/ — OM1, a leading real-world, data, outcomes and technology company with a focus on chronic diseases, today announced the expansion of its Giant Cell Arteritis (GCA) registry. GCA, also known as temporal arteritis, is a chronic inflammatory artery disease that causes head pain, joint pain, vision problems, and fever. GCA affects approximately 230,000 Americans,[…]

Analysis of Real-Word Data in Cardiovascular Disease: Missing Data and Predictive Modeling

Tues. January 26, 2021 2:00-3:00 PM Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with cardiovascular conditions such as heart failure where risk of mortality is high and comorbidities, varying symptom presentation, and disease progression drastically determine treatment pathways and outcomes. Join OM1’s Chief Medical Officer Dr. Gary Curhan[…]

New Edition Of The AHRQ Registries User’s Guide Released

BOSTON, Sept. 21, 2020 /PRNewswire/ — An update of “Registries for Evaluating Patient Outcomes: A User’s Guide: 4th Edition,” was released today, the fourth edition of a reference handbook from the U.S. Agency for Healthcare Research and Quality (AHRQ) that contains practical information on the design, operation, and analysis of patient registries. First published in 2007, the User’s Guide[…]